FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
050824NDACUMBERLAND001OMECLAMOX-PAKCAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE2011-02-08DiscontinuedNo
022110NDACUMBERLAND001VIBATIVPOWDER;INTRAVENOUSEQ 250MG BASE/VIALTELAVANCIN HYDROCHLORIDE2009-09-11DiscontinuedNo
002VIBATIVPOWDER;INTRAVENOUSEQ 750MG BASE/VIALTELAVANCIN HYDROCHLORIDE2009-09-11PrescriptionYes
022348NDACUMBERLAND PHARMS001CALDOLORSOLUTION;INTRAVENOUS400MG/4ML (100MG/ML)IBUPROFEN2009-06-11DiscontinuedNo
002CALDOLORSOLUTION;INTRAVENOUS800MG/8ML (100MG/ML)IBUPROFEN2009-06-11PrescriptionYes
003CALDOLORSOLUTION;INTRAVENOUS800MG/200ML (4MG/ML)IBUPROFEN2009-06-11PrescriptionYes
022198NDACUMBERLAND001SANCUSOFILM, EXTENDED RELEASE;TRANSDERMAL3.1MG/24HRGRANISETRON2008-09-12PrescriptionYes
022016NDACUMBERLAND PHARMS001VAPRISOLINJECTABLE; INJECTION20MGCONIVAPTAN HYDROCHLORIDE2007-02-28PrescriptionNo
021697NDACUMBERLAND001VAPRISOLINJECTABLE;INTRAVENOUS20MG/4ML (5MG/ML)CONIVAPTAN HYDROCHLORIDE2005-12-29DiscontinuedNo
002VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINERINJECTABLE;INTRAVENOUS20MG/100ML (0.2MG/ML)CONIVAPTAN HYDROCHLORIDE2005-12-29PrescriptionYes
021539NDACUMBERLAND PHARMS001ACETADOTEINJECTABLE;INTRAVENOUS6GM/30ML (200MG/ML)ACETYLCYSTEINE2004-01-23PrescriptionYes
074712ANDACUMBERLAND PHARMS001LACTULOSEFOR SOLUTION;ORAL10GM/PACKETLACTULOSE1997-12-10PrescriptionYes
002LACTULOSEFOR SOLUTION;ORAL20GM/PACKETLACTULOSE1997-12-10PrescriptionYes